Serum Leptin in Peritoneal Dialysis: Is It a Useful Biomarker Following Peritonitis?


David Johnson Department of Nephro , * , David Johnson 2 , *

1 Department of Nephro, Brisbane, Australia

2 Department of Nephrology, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia

Corresponding Authors:

How to Cite: Johnson D, Johnson D. Serum Leptin in Peritoneal Dialysis: Is It a Useful Biomarker Following Peritonitis?, Nephro-Urol Mon. 2011 ; 4(1):333-335. doi: 10.5812/kowsar.22517006.2626.


Nephro-Urology Monthly: 4 (1); 333-335
Published Online: December 18, 2011
Article Type: Editorial
Received: October 6, 2011
Revised: October 11, 2011
Accepted: October 21, 2011
Copyright © 2011, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.




  • 1.

    lameire N, Van Biesen W. Epidemiology of peritoneal dialysis: a story of believers and nonbeliever. Nat Rev Nephrol. 2010; 6(2) : 75 -82 [DOI][PubMed]

  • 2.

    Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl. 2006; 103 -11

  • 3.

    Davies SJ, Phillips l, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol. 2001; 12(5) : 1046 -51 [PubMed]

  • 4.

    Topley N. In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions. Perit Dial Int. 1997; 17(1)[PubMed]

  • 5.

    Topley N. Membrane longevity in peritoneal dialysis: impact of infection and bio-incompatible solutions. Adv Ren Replace Ther. 1998; 5(3) : 179 -84 [PubMed]

  • 6.

    Pecoits-Filho R, Stenvinkel P, heimburger o, lindholm B. Beyond the membrane-the role of new PD solutions in enhancing global biocompatibility. Kidney Int Suppl. 2003; 88 -32 [DOI][PubMed]

  • 7.

    Witowski J, Jorres A. Effects of peritoneal dialysis solutions on the peritoneal membrane: clinical consequences. Perit Dial Int. 2005; 25 -4 [PubMed]

  • 8.

    Schambye HT. Effect of different buffers on the biocompatibility of CAPD solutions. Perit Dial Int. 1996; 16 -6 [PubMed]

  • 9.

    Nau B, Schmitt CP, Almeida M, Arbeiter K, Ardissino G, Bonzel KE, et al. . BIoKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991]. BMC Nephrol. 2004; 5 : 14 [DOI][PubMed]